Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.jsb.2010.09.007
DC Field | Value | |
---|---|---|
dc.title | Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors | |
dc.contributor.author | Shenoy, R.T. | |
dc.contributor.author | Sivaraman, J. | |
dc.date.accessioned | 2014-10-27T08:40:33Z | |
dc.date.available | 2014-10-27T08:40:33Z | |
dc.date.issued | 2011-01 | |
dc.identifier.citation | Shenoy, R.T., Sivaraman, J. (2011-01). Structural basis for reversible and irreversible inhibition of human cathepsin L by their respective dipeptidyl glyoxal and diazomethylketone inhibitors. Journal of Structural Biology 173 (1) : 14-19. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jsb.2010.09.007 | |
dc.identifier.issn | 10478477 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/101746 | |
dc.description.abstract | Cathepsin L plays a key role in many pathophysiological conditions including rheumatoid arthritis, tumor invasion and metastasis, bone resorption and remodeling. Here we report the crystal structures of two analogous dipeptidyl inhibitor complexes which inhibit human cathepsin L in reversible and irreversible modes, respectively. To-date, there are no crystal structure reports of complexes of proteases with their glyoxal inhibitors or complexes of cathepsin L and their diazomethylketone inhibitors. These two inhibitors - inhibitor 1, an α-keto-β-aldehyde and inhibitor 2, a diazomethylketone, have different groups in the S1 subsite. Inhibitor 1 [Z-Phe-Tyr (OBut)-COCHO], with a Ki of 0.6nM, is the most potent, reversible, synthetic peptidyl inhibitor of cathepsin L reported to-date. The structure of the inhibitor 1 complex was refined up to 2.2Å resolution. The structure of the complex of the inhibitor 2 [Z-Phe-Tyr (t-Bu)-diazomethylketone], an irreversible inhibitor that can inactivate cathepsin L at μM concentrations, was refined up to 1.76Å resolution. These two inhibitors have substrate-like interactions with the active site cysteine (Cys25). Inhibitor 1 forms a tetrahedral hemithioacetal adduct, whereas the inhibitor 2 forms a thioester with Cys25. The inhibitor 1 β-aldehyde group is shown to make a hydrogen bond with catalytic His163, whereas the ketone carbonyl oxygen of the inhibitor 2 interacts with the oxyanion hole. tert-Butyl groups of both inhibitors are found to make several non-polar contacts with S' subsite residues of cathepsin L. These studies, combined with other complex structures of cathepsin L, reveal the structural basis for their potency and selectivity. © 2010 Elsevier Inc. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.jsb.2010.09.007 | |
dc.source | Scopus | |
dc.subject | Cathepsin L | |
dc.subject | Crystal structure | |
dc.subject | Cysteine proteases | |
dc.subject | Inhibitors | |
dc.type | Article | |
dc.contributor.department | BIOLOGICAL SCIENCES | |
dc.description.doi | 10.1016/j.jsb.2010.09.007 | |
dc.description.sourcetitle | Journal of Structural Biology | |
dc.description.volume | 173 | |
dc.description.issue | 1 | |
dc.description.page | 14-19 | |
dc.description.coden | JSBIE | |
dc.identifier.isiut | 000286123600002 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.